Veteran venture capitalist Yvonne Bajela has officially launched Evertrue Capital, a new fund that has closed oversubscribed at $17 million. Bajela, who brings over a decade of experience investing in prominent companies like Wise and Marshmallow, aims to leverage her expertise to support early-stage startups across the U.K. and Europe.

The fund’s strategy centers on early-stage investments, with an average check size of approximately £350,000. Evertrue Capital plans to back at least 20 companies over the next three years. Bajela expressed her motivation for launching her own firm, stating, “After more than a decade backing founders who bet everything on their ideas, it felt like time to make a bet of my own. I wanted the independence to act on those convictions and build something that reflected my own approach to investing.”

The current technological landscape, particularly the advancements in artificial intelligence, has significantly influenced Bajela’s decision to launch Evertrue. She believes the AI boom has not only altered the economics of company creation but also opened up new avenues for early-stage investors. Bajela noted, “The ability to build has been democratized. But the ability to build something enduring remains rare.” This sentiment aligns with the burgeoning startup ecosystem in the U.K., which is increasingly recognized for its innovation hubs and successful scaling companies.

Despite the challenging market for emerging fund managers, Evertrue Capital secured significant backing, including from institutional investors like the British Business Bank and Basecamp. Bajela emphasized the strategic importance of fund size, opting for a focused capital base to ensure meaningful investments rather than succumbing to deployment pressure. The fund’s limited partners are predominantly U.K.-based, with a notable international presence, reflecting Bajela’s global network and the fund’s ambition to support founders with international growth aspirations, particularly towards the U.S. market. Evertrue Capital will primarily focus on the AI and fintech sectors, seeking founders with unique insights, exceptional execution capabilities, and ambitious visions.

Key Takeaways

• Yvonne Bajela has launched Evertrue Capital, a new $17 million fund focused on early-stage European startups.
• The fund will concentrate on AI and fintech sectors, backing at least 20 companies with an average investment of £350,000.
• Evertrue Capital secured backing from institutional investors, including the British Business Bank, and aims to support founders with global ambitions.

Editor’s Analysis & Impact

The launch of Evertrue Capital signifies a positive development for Europe’s early-stage startup ecosystem, particularly in the AI and fintech sectors. Yvonne Bajela’s extensive experience as a VC and her strategic approach to fund management, prioritizing conviction over sheer capital size, are crucial differentiators in a competitive market. The fund’s focus on founders with unique insights and execution prowess, coupled with its international LP base, positions it well to identify and nurture the next generation of globally significant businesses emerging from Europe. This move by Bajela not only highlights her entrepreneurial spirit but also underscores the growing confidence in the European tech scene’s potential for innovation and scale.

Frequently Asked Questions

Q: What is Evertrue Capital's investment focus?
A: Evertrue Capital primarily focuses on early-stage investments in the AI and fintech sectors across the U.K. and Europe. They seek founders with unique insights, strong execution abilities, and ambitious growth plans.

Q: How much capital does Evertrue Capital plan to deploy?
A: The fund has closed at $17 million and plans to back at least 20 companies over the next three years, with an average investment check size of around £350,000.

Q: Who are some of the backers of Evertrue Capital?
A: Evertrue Capital has secured backing from several institutional investors, including the British Business Bank and Basecamp, among others.